Iris Halfpenny

Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.

Charlie Gourley, Andrena McCavigan, Timothy Perren et al. · Journal of Clinical Oncology · 2014 · 123 citations

Medicine, Oncology, Pharmacology +16

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

Joseph Foster, Assa Oumie, Fiona S. Togneri et al. · BMC Medical Genomics · 2015 · 92 citations · Full text

Medicine, Molecular Genetics, Pathology +17

The silent <i>KIR3DP1</i> gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the <i>KIR3DP1</i>, <i>KIR2DL4</i> and <i>KIR3DL1</i>/<i>KIR3DS1</i> genes are duplicated

Natalia Gómez‐Lozano, E. Estefanía, Fionnuala Williams et al. · European Journal of Immunology · 2004 · 76 citations · Full text

Life Sciences, Genetics, Immunology +16

Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals

Fionnuala Williams, Lynn D Maxwell, Iris Halfpenny et al. · Human Immunology · 2003 · 48 citations

Life Sciences, Genetics, Molecular Genetics +6

Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1

Iris Halfpenny, Derek Middleton, Yvonne Barnett et al. · Human Immunology · 2004 · 38 citations

Life Sciences, Genetics, Immunology +8